Sfoglia per AUTORE
MATTA M
Collezione AOU San Luigi di Orbassano

  

Items : 16

Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern Italy. in Nutrients / Nutrients. 2024 Mar 18;16(6):880. doi: 10.3390/nu16060880.

2024
AOU San Luigi di Orbassano

Bronzini M; Maglione A; Rosso R; Masuzzo F; Matta M; Meroni R; Rolla S; Clerico M;

Feeding the gut microbiome: impact on multiple sclerosis. in Frontiers in immunology / Front Immunol. 2023 May 25;14:1176016. doi: 10.3389/fimmu.2023.1176016. eCollection 2023.

2023
AOU San Luigi di Orbassano

Bronzini M; Maglione A; Rosso R; Matta M; Masuzzo F; Rolla S; Clerico M;

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis. in Frontiers in immunology / Front Immunol. 2023 Jun 19;14:1205879. doi: 10.3389/fimmu.2023.1205879. eCollection 2023.

2023
AOU San Luigi di Orbassano

Maglione A; Francese R; Arduino I; Rosso R; Matta M; Rolla S; Lembo D; Clerico M;

Source of medical information and behavioral seeking patterns in patients affected with Friedreich's ataxia and their caregivers: a survey study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2022 May;43(5):3223-3229. doi: 10.1007/s10072-021-05738-6. Epub 2021 Nov 28.

2022
AOU San Luigi di Orbassano

Miele G; Lavorgna L; De Mercanti SF; Iudicello M; Abbadessa G; Matta M; Bonavita S; Clerico M; Miele G; Lavorgna L; De Mercanti SF; Iudicello M; Abbadessa G; Matta M; Bonavita S; Clerico M;

Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):914-920. doi: 10.1136/jnnp-2019-322480. Epub 2020 Jul

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Spinicci G; Spitaleri D; Sessa E; Rovaris M; Righini I; Pontecorvo S; Petrucci L; Matta M; Paolicelli D; Maniscalco GT; Lus G; Lanzillo R; Guareschi A; Gasperini C; Gajofatto A; Esposito F; Danni MC; Cottone S; Centonze D; Costantino G; Castelli L; Cavalla P; Capello E; Bruno Bossio R; Brescia Morra V; Bonavita S; Bianco A; Bergamaschi R; Annunziata P; et alii...

Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study. in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Oct;41(10):2905-2913. doi: 10.1007/s10072-020-04413-6. Epub 2020 Apr 25.

2020
AOU San Luigi di Orbassano

Patti F; Chisari CG; Solaro C; Benedetti MD; Berra E; Bianco A; Bruno Bossio R; Buttari F; Castelli L; Cavalla P; Cerqua R; Costantino G; Gasperini C; Guareschi A; Ippolito D; Lanzillo R; Maniscalco GT; Matta M; Paolicelli D; Petrucci L; Pontecorvo S; Righini I; Russo M; Saccà F; Salamone G; Signoriello E; Spinicci G; Spitaleri D; Tavazzi E; et alii...

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question. in Journal of investigative medicine high impact case reports / J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620939802. doi: 10.1177/2324709620939802.

2020
AOU San Luigi di Orbassano

Matta M; Iudicello M; Gned D; De Mercanti SF; Franchin E; Clerico M;

No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study. in Journal of neurology / J Neurol. 2018 Dec;265(12):2851-2860. doi: 10.1007/s00415-018-9070-x. Epub 2018 Sep 26.

2018
AOU San Luigi di Orbassano

Prosperini L; Annovazzi P; Boffa L; Buscarinu MC; Gallo A; Matta M; Moiola L; Musu L; Perini P; Avolio C; Barcella V; Bianco A; Farina D; Ferraro E; Pontecorvo S; Granella F; Grimaldi LME; Laroni A; Lus G; Patti F; Pucci E; Pasca M; Sarchielli P;

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study. in Journal of neurology / J Neurol. 2018 Aug;265(8):1850-1859. doi: 10.1007/s00415-018-8916-6. Epub 2018 Jun 14.

2018
AOU San Luigi di Orbassano

Mallucci G; Annovazzi P; Miante S; Torri-Clerici V; Matta M; La Gioia S; Cavarretta R; Mantero V; Costantini G; D'Ambrosio V; Zaffaroni M; Ghezzi A; Perini P; Rossi S; Bertolotto A; Rottoli MR; Rovaris M; Balgera R; Cavalla P; Montomoli C; Bergamaschi R;

Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment. in Frontiers in neurology / Front Neurol. 2018 Feb 5;9:31. doi: 10.3389/fneur.2018.00031. eCollection 2018.

2018
AOU San Luigi di Orbassano

Serra A; Chisari CG; Matta M;

Computerized posturography is more sensitive than clinical Romberg Test in detecting postural control impairment in minimally impaired Multiple Sclerosis patients. in Multiple sclerosis and related disorders / Mult Scler Relat Disord. 2017 May;14:51-55. doi: 10.1016/j.msard.2017.03.008. Epub 2017 Mar 23.

2017
AOU San Luigi di Orbassano

Melillo F; Di Sapio A; Martire S; Malentacchi M; Matta M; Bertolotto A;

High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study. in Neurology and therapy / Neurol Ther. 2017 Jun;6(1):145-152. doi: 10.1007/s40120-016-0058-0. Epub 2016 Dec 3.

2017
AOU San Luigi di Orbassano

Malucchi S; Capobianco M; Lo Re M; Malentacchi M; di Sapio A; Matta M; Sperli F; Bertolotto A;

Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study). in PloS one / PLoS One. 2017 Aug 1;12(8):e0180651. doi: 10.1371/journal.pone.0180651. eCollection 2017.

2017
AOU San Luigi di Orbassano

Messina S; Solaro C; Righini I; Bergamaschi R; Bonavita S; Bossio RB; Brescia Morra V; Costantino G; Cavalla P; Centonze D; Comi G; Cottone S; Danni MC; Francia A; Gajofatto A; Gasperini C; Zaffaroni M; Petrucci L; Signoriello E; Maniscalco GT; Spinicci G; Matta M; Mirabella M; Pedà G; Castelli L; Rovaris M; Sessa E; Spitaleri D; Paolicelli D; et alii...

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity. in Journal of neurology, neurosurgery, and psychiatry / J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):944-51. doi: 10.1136/jnnp-2015-312591. Epub 2016 May 9

2016
AOU San Luigi di Orbassano

Patti F; Messina S; Solaro C; Amato MP; Bergamaschi R; Bonavita S; Bruno Bossio R; Brescia Morra V; Costantino GF; Cavalla P; Centonze D; Comi G; Cottone S; Danni M; Francia A; Gajofatto A; Gasperini C; Ghezzi A; Iudice A; Lus G; Maniscalco GT; Marrosu MG; Matta M; Mirabella M; Montanari E; Pozzilli C; Rovaris M; Sessa E; Spitaleri D; et alii...

No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation. in European journal of neurology / Eur J Neurol. 2015 Mar;22(3):585-7. doi: 10.1111/ene.12487. Epub 2014 Jul 3.

2015
AOU San Luigi di Orbassano

Capobianco M; di Sapio A; Malentacchi M; Malucchi S; Matta M; Sperli F; Bertolotto A;

Biological monitoring of IFN-? therapy in Multiple Sclerosis. in Cytokine & growth factor reviews / Cytokine Growth Factor Rev. 2015 Apr;26(2):241-8. doi: 10.1016/j.cytogfr.2014.12.002. Epub 2014 Dec

2015
AOU San Luigi di Orbassano

Bertolotto A; Granieri L; Marnetto F; Valentino P; Sala A; Capobianco M; Malucchi S; Di Sapio A; Malentacchi M; Matta M; Caldano M;